Interventions | 2014 Baseline (%) | 2023 Endline | ||
---|---|---|---|---|
Projection 1 target (%) | Projection 2 target (%) | PRODESS/PDDSS target (%) | ||
Contraceptive prevalence | 11 | 20 | 20 | 20 |
Antenatal care | 41 | 55 | 50 | 65 |
Tetanus toxoid vaccination | 42 | 80 | 80 | Ìý |
Pregnant women protected by insecticide treated bednets (ITN) | 73 | 90 | 90 | Ìý |
Iron Supplementation | 22 | 30 | 30 | Ìý |
Malaria case management | 0 | 5 | 5 | Ìý |
Skilled birth attendance | 60 | 90 | 90 | 90 |
Health facility delivery | 60 | 90 | 90 | Ìý |
Basic Emergency Obstetric and Newborn Care (BEmOC) | 9 | 30 | 35 | 9 |
Exclusive breastfeeding (0 – 1Ìýmonth) | 59 | 90 | 90 | Ìý |
Exclusive breastfeeding (1 – 5Ìýmonth) | 31 | 70 | 70 | Ìý |
Clean postnatal practices | 16 | 30 | 30 | Ìý |
Vitamin A supplementation | 61 | 70 | 80 | Ìý |
Zinc supplementation | 0 | 4 | 4 | Ìý |
Improved water source | 66 | 80 | 80 | Ìý |
Water connection in the home | 9 | 10 | 10 | Ìý |
Utilization of latrines or toilets | 24 | 30 | 30 | 30 |
Hand washing with soap | 17 | 50 | 50 | Ìý |
Ownership of ITNs | 84 | 95 | 95 | Ìý |
DPT-three doses | 74 | 98 | 98 | 98 |
Hemophilus. influenzae B (HiB) – three doses | 74 | 98 | 98 | 98 |
Hepatitis B vaccine (HepB) – three doses | 74 | 98 | 98 | 98 |
Measles – single dose | 72 | 98 | 98 | 98 |
BCG – single dose | 87 | 98 | 98 | Ìý |
Rotavirus two doses | 0 | 20 | 20 | Ìý |
Pneumococcal – three doses | 74 | 98 | 98 | Ìý |
Polio – three doses | 81 | 98 | 98 | Ìý |
Thermal care | 16 | 45 | 45 | Ìý |
Oral antibiotic for newborn | 7 | 20 | 15 | Ìý |
Vitamin A for Measles treatment | 61 | 70 | 70 | Ìý |
Newborn sepsis case management | 27 | 55 | 55 | Ìý |
ORS – oral rehydration solution | 37 | 50 | 60 | Ìý |
Antibiotic for treatment of dysentery | 15 | 30 | 50 | Ìý |
Zinc – for treatment of diarrhea | 2 | 30 | 20 | Ìý |
Oral antibiotic for pneumonia | 27 | 40 | 50 | Ìý |
Artemisinin for malaria | 15 | 40 | 50 | Ìý |
Stunting | 38 | 8 | 15 | 15 |
Wasting | 13 | 4 | 5 | 5 |